Illumina, Inc.
—- Market cap
- $31.17B
- Debt
- —
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $31.17B · View financials
Snapshot Sep 11, 2026, 4:00 PM ET
FY 2026 · View financials
Decision snapshot: ILMN stock price vs TXT: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TXT's multiple
Needs TXT P/E.
Implied fair value · at ILMN's multiple
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Higher is better
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
12 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ILLUMINA, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Textron Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
THERMO FISHER SCIENTIFIC INC.
ILMN vs TMO
AGILENT TECHNOLOGIES, INC.
ILMN vs A
DANAHER CORP /DE/
ILMN vs DHR
BIO-RAD LABORATORIES, INC.
ILMN vs BIO
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
ILMN vs PACB
Natera, Inc.
ILMN vs NTRA
BOEING CO
ILMN vs BA
LOCKHEED MARTIN CORP
ILMN vs LMT
NORTHROP GRUMMAN CORP /DE/
ILMN vs NOC
Howmet Aerospace Inc.
ILMN vs HWM
CURTISS WRIGHT CORP
ILMN vs CW
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ILMN's high margins, 31.8% ROIC, and strong balance sheet will remain durable despite -0.7% revenue growth, then ILMN looks attractive on a relative quality basis; if not, the 49.3% downside to the implied price suggests caution because the valuation is well above DCF.
ILMN trades at 34.5x P/E versus TXT at 17.5x, but the implied price of $95.38 is 49.3% below the current price of $187.96, indicating the stock is rich versus a DCF framework. The current price sits above the top of the DCF range ($97.28) and within the historical band ($169.16-$206.76), suggesting the market is pricing ILMN closer to its own trading history than its discounted cash flow value.
Supporting Metrics